Shares of Tata Consultancy Services (TCS) traded 1.5 per cent lower at Rs 3,273 on the BSE on Monday, outperforming the market, ahead of its January-March 2021 (Q4FY21) results today. In comparison, the S&P BSE Sensex was down 3.55 per cent or 1,758 points at 47,833, at 1:25 PM. The stock hit an intra-day high of Rs 3,344 and a low of Rs 3,241 on the BSE.
In the past one month, shares of the information technology (IT) giant rose 7 per cent, as compared to 5.7 per cent slide in the benchmark index. However, in the last six months, it has underperformed the market by gaining 16 per cent, against 18 per cent surge in the Sensex.
Poland s Mabion aims to produce Novavax vaccine for Europe from Q3
01 Apr 2021 - 16:55
A woman holds a small bottle labeled with a Coronavirus COVID-19 Vaccine sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic/File Photo
Reuters
WARSAW: Poland s Mabion aims to start production of U.S. firm Novavax s coronavirus vaccine for Europe from the third quarter, representatives of the biotechnology company said.
Mabion and Novavax last month signed a framework deal on the transfer of COVID-19 vaccine technology to Mabion s plant in central Poland, which was designed to produce a rare diseases drug yet to be registered.